LINC01133 and esophageal squamous cell carcinoma: It is demonstrated that LINC01133 acts as a tumor suppressor in gastric cancer [11], nasopharyngeal cancer [12], oral [13] esophageal squamous cell carcinoma (ESCC) [14], and colorectal cancer [15].